Clinical effect of percutaneous hepatic puncture biliary drainage combined with metal stent implantation in the treatment of malignant obstructive jaundice

被引:0
作者
Zhang, Shoulin [1 ]
Huang, Shaopeng [2 ]
Xing, Zheng [1 ]
Song, Youwen [1 ]
Yuan, Fujian [1 ,3 ]
机构
[1] Ganzhou Canc Hosp, Dept Intervent Therapy, Ganzhou City, Jiangxi Provinc, Peoples R China
[2] Ganzhou Dayu Cty Peoples Hosp, Dept Oncol, Ganzhou City, Jiangxi Provinc, Peoples R China
[3] Ganzhou Canc Hosp, Dept Intervent Therapy, 19 Garden Front, Ganzhou City, Jiangxi Provinc, Peoples R China
关键词
Percutaneous hepatic puncture biliary drainage; Metal stent implantation; Malignant obstructive jaundice; ULTRASOUND-GUIDED HEPATICOGASTROSTOMY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; RADIOFREQUENCY ABLATION; MULTICENTER; SAFETY;
D O I
10.1186/s12893-025-02807-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective To evaluate the clinical efficacy of percutaneous hepatic puncture biliary drainage combined with metal stent implantation in the treatment of malignant obstructive jaundice, focusing on improvements in liver function, bile duct patency time, and reduction of postoperative complications. Methods 181 patients with malignant obstructive jaundice were retrospectively selected from a hospital in Ganzhou City, Jiangxi Province, from April 2021 to May 2024, of which 132 underwent routine percutaneous liver puncture biliary drainage and 49 underwent percutaneous liver puncture biliary drainage combined with metal stent implantation as the observation group. Results The clinical efficacy of the observation group was higher (P < 0.05), and the bile duct patency time was longer (P < 0.05). The AST, ALT, DBIL and TBIL levels were decreased 1 week and 1 month after surgery, and the decrease was more significant in the observation group (P < 0.05). In addition, the incidence of postoperative complications (bile duct infection and electrolyte disturbance) in the observation group was lower (P < 0.05). Conclusion Percutaneous hepatic puncture biliary drainage combined with metal stent implantation has significant clinical efficacy, which can effectively improve the clinical symptoms of patients, prolong the biliary patency time, reduce the level of bilirubin, promote the improvement of liver function, and lower the incidence of postoperative complications.
引用
收藏
页数:7
相关论文
共 39 条
  • [1] Xu J., Zhuang S., Liu M., Wu S., Li H., Prognostic effects of different malignant obstructive jaundice sites on percutaneous biliary intervention: a retrospective controlled study, J Cancer Res Ther, 19, pp. 78-85, (2023)
  • [2] Huang X.H., Wu S.H., Li P., Ke Q., Weng X.T., Li L., Et al., [Percutaneous biliary stent combined with brachytherapy for malignant obstructive jaundice: a multicenter retrospective controlled study], Zhonghua Gan Zang Bing Za Zhi, 30, pp. 702-709, (2022)
  • [3] Dhondt E., Vanlangenhove P., Geboes K., Vandenabeele L., Van Cauwenberghe L., Defreyne L., No evidence of improved efficacy of covered stents over uncovered stents in percutaneous palliation of malignant hilar biliary obstruction: results of a prospective randomized trial, Eur Radiol, 30, pp. 175-185, (2020)
  • [4] Li M.Q., Zhang J.X., Lu C.H., Pan H., Ru F.M., Cao C.W., Et al., [Long-term outcome of interventional therapy for malignant biliary obstruction: a retrospective analysis of 109 cases], Zhonghua Yi Xue Za Zhi, 88, pp. 2743-2747, (2008)
  • [5] Qi S., Yan H., Effect of percutaneous transhepatic cholangial drainag + radiofrequency ablation combined with biliary stent implantation on the liver function of patients with cholangiocarcinoma complicated with malignant obstructive jaundice, Am J Transl Res, 13, pp. 1817-1824, (2021)
  • [6] Keshaw P.B., Bernon M., Emmamally M., Khan R., Segobin R., Creamer D., Et al., Outcomes of jaundice in advanced hepatocellular carcinoma - a sub-saharan perspective, S Afr J Surg, 62, pp. 18-22, (2024)
  • [7] Singh S., Sawal A., Comprehensive Review on pancreatic Head Cancer: Pathogenesis, diagnosis, and Treatment challenges in the Quest for Improved Survival, Cureus, 16, (2024)
  • [8] Xing D., Song W., Gong S., Xu A., Zhai B., Analysis of the bacterial spectrum and key clinical factors of biliary tract infection in patients with malignant obstructive jaundice after PTCD, Dis Markers, 2022, (2022)
  • [9] Sportes A., Camus M., Greget M., Leblanc S., Coriat R., Hochberger J., Et al., Endoscopic ultrasound-guided hepaticogastrostomy versus percutaneous transhepatic drainage for malignant biliary obstruction after failed endoscopic retrograde cholangiopancreatography: a retrospective expertise-based study from two centers, Th Adv Gastroenterol, 10, pp. 483-493, (2017)
  • [10] Kongkam P., Tasneem A.A., Rerknimitr R., Combination of endoscopic retrograde cholangiopancreatography and endoscopic ultrasonography-guided biliary drainage in malignant hilar biliary obstruction, Dig Endosc, 31, pp. 50-54, (2019)